[Therapeutic options in hormone refractory prostate carcinoma]
Standard
[Therapeutic options in hormone refractory prostate carcinoma]. / Graefen, M; Hammerer, P; Haese, Alexander; Huland, H.
In: UROLOGE, Vol. 39, No. 3, 3, 2000, p. 267-273.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
Graefen, M, Hammerer, P, Haese, A & Huland, H 2000, '[Therapeutic options in hormone refractory prostate carcinoma]', UROLOGE, vol. 39, no. 3, 3, pp. 267-273. <http://www.ncbi.nlm.nih.gov/pubmed/10872254?dopt=Citation>
APA
Graefen, M., Hammerer, P., Haese, A., & Huland, H. (2000). [Therapeutic options in hormone refractory prostate carcinoma]. UROLOGE, 39(3), 267-273. [3]. http://www.ncbi.nlm.nih.gov/pubmed/10872254?dopt=Citation
Vancouver
Graefen M, Hammerer P, Haese A, Huland H. [Therapeutic options in hormone refractory prostate carcinoma]. UROLOGE. 2000;39(3):267-273. 3.
Bibtex
@article{ca584ac55d544c8682520d0e99102c82,
title = "[Therapeutic options in hormone refractory prostate carcinoma]",
author = "M Graefen and P Hammerer and Alexander Haese and H Huland",
year = "2000",
language = "Deutsch",
volume = "39",
pages = "267--273",
journal = "UROLOGE",
issn = "0340-2592",
publisher = "Springer",
number = "3",
}
RIS
TY - JOUR
T1 - [Therapeutic options in hormone refractory prostate carcinoma]
AU - Graefen, M
AU - Hammerer, P
AU - Haese, Alexander
AU - Huland, H
PY - 2000
Y1 - 2000
M3 - SCORING: Zeitschriftenaufsatz
VL - 39
SP - 267
EP - 273
JO - UROLOGE
JF - UROLOGE
SN - 0340-2592
IS - 3
M1 - 3
ER -
